PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE
申请人:Bradley Edward Stuart
公开号:US20070244090A9
公开(公告)日:2007-10-18
Compounds represented by Formula (I):
or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.
Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
申请人:Thomas Gerard Hugh
公开号:US20090298745A1
公开(公告)日:2009-12-03
The invention provides a method of treatment of diabetes, particularly type II diabetes, or a diabetes related condition, comprising night time dosing of an inhibitor of glycogen phosphorylase, optionally in combination another anti-diabetic therapy.